Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment (SING-PD)

This study has been completed.
Sponsor:
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01163331
First received: July 14, 2010
Last updated: June 20, 2011
Last verified: June 2011

July 14, 2010
June 20, 2011
March 2010
August 2010   (final data collection date for primary outcome measure)
Vocal Loudness, Vocal Quality [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01163331 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment
Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing

This study will compare group singing to group speech therapy without singing. You may be eligible for this study if you have been diagnosed with PD for one year or more and you have a quiet voice or difficulty being understood.

The National Parkinson Foundation Center of Excellence at Beth Israel Deaconess Medical Center is conducting a research study to test whether group singing therapy helps people with voice or speech disorders due to Parkinson's disease (PD). Communication problems, including loss of vocal loudness, affect many people with PD. While existing forms of speech therapy have been shown to be helpful, group singing may be a beneficial alternative to traditional speech therapy.

The study will involve participating in weekly treatment sessions where subjects will receive training in vocal exercises from a speech-language pathologist with expertise in PD, as well as instructions for structured home practice. Participants will be assigned to a singing or non-singing group for the 12-week treatment phase of the study. Researchers will measure subjects' vocal function and communication-related quality of life before and several times after the 12-week program. All subjects and their care partners are welcome to participate in a singing group following the study.

You may be eligible for this study if you have been diagnosed with PD for one year or more, and you have difficulty with your voice or speech such as quiet voice, or difficulty being understood.

Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Voice Quality and Voice Loudness Associated With Parkinson's Disease
Other: Singing Therapy
Singing therapy as a way to improve voice quality
Experimental: Singing Therapy Group
Singing Therapy Group
Intervention: Other: Singing Therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
Not Provided
August 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Difficulty being heard or understood
  • Diagnosis of Parkinson's Disease for one year

Exclusion Criteria:

  • No other neurological conditions(i.e. stroke, cerebellar ataxia) that affect voice quality
  • No history of vocal chord hemorrhage
Both
30 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01163331
2009-P-000338/1
No
Dr. Daniel Tarsy, MD, Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Michael J. Fox Foundation for Parkinson's Research
Not Provided
Beth Israel Deaconess Medical Center
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP